1. Home
  2. Proposition 65
  3. October 17, 2003 Meeting of the Science Advisor...

October 17, 2003 Meeting of the Science Advisory Board's Carcinogen Identification Committee

The California Environmental Protection Agency's Office of Environmental Health Hazard Assessment (OEHHA) is the lead agency for the implementation of the Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65).

The Carcinogen Identification Committee (CIC) of OEHHA's Science Advisory Board identifies chemicals for addition to the list of chemicals known to the State to cause cancer, which is mandated by Health and Safety Code Section 25249.8. The Committee serves as the "State's qualified experts" for determining whether a chemical has been clearly shown, through scientifically valid testing according to generally accepted principles, to cause cancer.

A public meeting of this committee will be held on Friday, October 17, 2003 at the California Environmental Protection Agency Headquarters Building, Sierra Hearing Room, at 1001 I Street, Sacramento, California, beginning at 10:00 a.m. and continuing until all business has been conducted, or 5:00 p.m.

The tentative agenda for this meeting is as follows. It should be noted that the order of items on the agenda is provided for general reference only. The order in which items are taken up by the Committee is subject to change at the discretion of the Chair.

I. CONSIDERATION OF A CHEMICAL AS KNOWN TO THE STATE TO CAUSE CANCER

  • Chloral Hydrate
  • Staff presentation
  • Committee discussion
  • Public comments
  • Committee discussion and decision

II. CONSIDERATION OF PROPOSED ACRYLAMIDE WORK PLAN

A. Proposed Work plan

  • Staff presentation
  • Committee discussion
  • Public comments
  • Committee discussion and recommendation on overall work plan

B. Part 1. No Significant Risk Level (NSRL)

  • Staff presentation
  • Committee discussion
  • Public comments
  • Committee discussion and recommendation on whether the NSRL should be updated, and if so, factors to consider

III. UPDATES

  • Status of chemical listings via the administrative listing mechanisms
  • Status of hazard identification documents preparation for statin drugs
  • Status of subcommittee discussions on prioritization procedure
  • Public comments

IV. SUMMARY OF COMMITTEE ACTIONS

Downloads